Similarly to probiotics, which are also able to enhance anti-inflammatory cytokines and decrease pro-inflammatory cytokines, probiotics are also believed to block the NF-κB pathway, showing possibilities for a synergistic approach with vitamin D to further reduce inflammation in SLE (51, 147, 166). This evidence concerns the gene NFKB1 and systemic lupus erythematosus.